Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.
Address correspondence and reprint requests to Joseph Jankovic, MD, Department of Neurology, Baylor College of Medicine, 7200 Cambridge, Suite 9A, Houston, TX 77030; E-mail: [email protected]
Conflicts of Interest and Source of Funding: J.J. has received research and/or training grants from Adamas Pharmaceuticals, Inc; Allergan, Inc; Biotie Therapies; CHDI Foundation; Civitas/Acorda Therapeutics; Dystonia Coalition; Dystonia Medical Research Foundation; F. Hoffmann-La Roche Ltd; Huntington Study Group; Kyowa Haako Kirin Pharma, Inc; Medtronic Neuromodulation; Merz Pharmaceuticals; Michael J. Fox Foundation for Parkinson Research; National Institutes of Health; Neurocrine Biosciences; NeuroDerm Ltd; Parkinson's Foundation; Nuvelution; Parkinson Study Group; Pfizer Inc; Prothena Biosciences Inc; Psyadon Pharmaceuticals, Inc; Revance Therapeutics, Inc; Sangamo BioSciences, Inc; St Jude Medical; and Teva Pharmaceutical Industries Ltd. J.J. has served as a consultant or as an advisory committee member for Adamas Pharmaceuticals, Inc; Allergan, Inc; Merz Pharmaceuticals; Pfizer Inc; Prothena Biosciences; Revance Therapeutics, Inc; and Teva Pharmaceutical Industries Ltd. He has received royalties or other payments from Cambridge; Elsevier; Future Science Group; Hodder Arnold; Medlink: Neurology; Lippincott Williams and Wilkins; and Wiley-Blackwell. N.N. has no conflicts of interest to declare.
Author Contributions: N.N.: Conception, design, organization, execution, and writing of the first and subsequent drafts. J.J.: Conception, design, organization, execution, review and critique, and writing of the second and subsequent drafts.
